Attenuation of withdrawal-induced hyperactivity of locus coeruleus neurones by inhibitors of nitric oxide synthase in morphine-dependent rats

Neuropharmacology

Volumn 37, Issue 6, 1998, Pages 759-767

  Pineda, Joseba ^a   Torrecilla, María ^a   Martín Ruiz, Raúl ^a   Ugedo, Luisa ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Electrophysiology; Locus coeruleus; Morphine; Nitric oxide synthase inhibitor; Opiate dependence; Opiate withdrawal

Indexed keywords

7 NITROINDAZOLE; CYCLIC GMP DEPENDENT PROTEIN KINASE; MORPHINE; N(G) NITROARGININE METHYL ESTER; NALOXONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; DOSE RESPONSE; DRUG WITHDRAWAL; ENZYME INHIBITION; HYPERACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; LOCUS CERULEUS; MALE; NEUROPHARMACOLOGY; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RAT;

ANIMALS; ELECTROPHYSIOLOGY; ENZYME INHIBITORS; INDAZOLES; LOCUS COERULEUS; MALE; MORPHINE; NEURONS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0031811654     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00063-X     Document Type: Article

References (47)

1. Adams M.L., Kalicki J.M., Meyer E.R., Cicero T.J. Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor. NG-nitro-l-arginine methyl ester. Life Sci. 52:1993;245-249.
2. Aghajanian G.K. Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature. 276:1978;186-188.
3. Aghajanian G.K., Kogan J.H., Moghaddam B. Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study. Brain Res. 636:1994;126-130.
4. Akaoka H., Aston-Jones G. Opiate withdrawal-induced hyperactivity of locus coeruleus neurons in substantially mediated by augmented excitatory amino acid input. J. Neurosci. 11:1991;3830-3839.
5. Alreja M., Aghajanian G.K. Opiates suppress a resting sodium-dependent inward current and activate an outward potassium current in locus coeruleus neurons. J. Neurosci. 13:1993;3525-3532.
6. Babbedge R.C., Bland-Ward P.A., Hart S.L., Moore P.K. Inhibition of rat cerebellar nitric oxide synthase by 7-nitroindazole and related substituted indazoles. Br. J. Pharmacol. 110:1993;225-228.
7. Bhargava H.N., Thorat S.N. Evidence for a role of nitric oxide of the central nervous system in morphine abstinence syndrome. Pharmacology. 52:1996;86-91.
8. Buccafusco J.J., Terry A.V. Jr., Shuster L. Spinal NMDA receptor-nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat. Brain Res. 679:1995;189-199.
9. Cappendijk S.L.T., de Vries R., Dzoljic M.R. Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Neurosci. Lett. 162:1993;97-100.
10. Cedarbaum J.M., Aghajanian G.K. Noradrenergic neurons of the locus coeruleus: inhibition by epinephrine and activation by the α-antagonist piperoxane. Brain Res. 112:1976;413-419.
11. Christie M.J., Williams J.T., Osborne P.B., Bellchambers C.E. Where is the locus in opioid withdrawal? Trends Pharmacol. Sci. 18:1997;134-140.
12. Desvignes C., Robert F., Vachetter C., Chouvet G., Cespuglio R., Renaud B., Lambàs-Señas L. Monitoring nitric oxide (NO) in rat locus coeruleus: differential effects of NO synthase inhibitors. Neuroreport. 8:1997;1321-1325.
13. Done C., Silverstone P., Sharp T. Effect of naloxone-precipitate morphine withdrawal on noradrenaline release in rat hippocampus in vivo. Eur. J. Pharmacol. 215:1992;333-336.
14. G-nitro-L-arginine are anxiolytic and are devoid of benzodiazepine side-effects in rats. Soc. Neurosci. Abs. 21 (544.4).
15. Garthwaite J., Boulton C.L. Nitric oxide signaling in the central nervous system. Ann. Rev. Physiol. 57:1995;683-706.
16. Garthwaite J., Charles S.L., Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature. 336:1988;385-388.
17. Gonon F., Buda M., de Simoni G., Pujol J.-F. Catecholamine metabolism in the rat locus coeruleus as studied by in vivo differential pulse voltammetry, II: pharmacological and behavioral study. Brain Res. 273:1983;207-216.
18. Griffith O.W., Stuehr D.J. Nitric oxide synthases: properties and catalytic mechanism. Annu. Rev. Physiol. 57:1995;707-736.
19. Hall S., Milne B., Jhamandas K. Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: an in vivo voltammetric study. Brain Res. 739:1996;182-191.
20. Highfield D.A., Grant S.J., Revay R.S. Nitric oxide modulates opioid tolerance in LC neuronal activity in vitro. Soc. Neurosci. Abs. 19(596.16):1993;1460.
21. Karatinos J., Rosse R.B., Deutsch S.I. The nitric oxide pathway: potential implications for treatment of neuropsychiatric disorders. Clin. Neuropharmacol. 18:1995;482-499.
22. Kimes A.S., Vaupel D.B., London E.D. Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase. Psychopharmacology. 112:1993;521-524.
23. Krystal J.H., Compere S., Nestler E.J., Rasmussen K. Nimodipine reduction of naltrexone-precipitated locus coeruleus activation and abstinence behavior in morphine-dependent rats. Physiol. Behav. 59:1996;863-866.
24. Leza J.-C., Lizasoain I., Cuéllar B., Moro M.A., Lorenzo P. Correlation between brain nitric oxide synthase activity and opiate withdrawal. Naunyn-Schmiedeberg's Arch. Pharmacol. 353:1996;349-354.
25. Majeed N.H., Przewlocka B., Machelska H., Przewlocki R. Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology. 33:1994;189-192.
26. Maldonado R., Koob G.F. Destruction of the locus coeruleus decreases physical sings of opiate withdrawal. Brain Res. 605:1993;128-138.
27. Maldonado R., Stinus L., Gold L.H., Koob G.F. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther. 261:1992;669-677.
28. Maldonado R., Valverde O., Garbay C., Roques B.P. Protein kinases in the locus coeruleus and periaqueductal gray matter are involved in the expression of opiate withdrawal. Naunyn-Schmiedeberg's Arch. Pharmacol. 352:1995;565-575.
29. Matsuoka I., Giuili G., Poyard M., Stengel D., Parma J., Guellaen G., Hanoune J. Localization of adenylyl and guanylyl cyclase in rat brain by in situ hybridization: comparison with calmodulin mRNA distribution. J. Neurosci. 12:1992;3350-3360.
30. Moore P.K., Babbedge R.C., Wallace P., Gaffen Z.A., Hart S.L. 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br. J. Pharmacol. 108:1993;296-297.
31. Nestler E.J., Alreja M., Aghajanian G.K. Molecular and cellular mechanisms of opiate action: studies in the rat locus coeruleus. Brain Res. Bull. 35:1994;521-528.
32. Parker R.B., Waud D.R. Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists. J. Pharmacol. Exp. Ther. 177:1971;1-12.
33. Pasternak G.W., Kolesnikov Y.A., Babey A.-M. Perspectives on the N-methyl-D-aspartate-nitric oxide cascade and opioid tolerance. Neuropsychopharmacology. 13:1995;309-313.
34. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates (2nd edn.). Academic Press, Orlando.
35. Pineda J., Ugedo L. Activation of rat locus coeruleus neurons in opioid withdrawal is reduced by inhibition of nitric oxide synthase in vivo. Soc. Neurosci. Abs. 22(520.8):1996;1310.
36. Pineda J., Ugedo L., García-Sevilla J.A. Stimulatory effects of clonidine, cirazoline and rilmenidine on locus coeruleus noradrenergic neurones: possible involvement of imidazoline-preferring receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 348:1993;134-140.
37. Pineda J., Kogan J.H., Aghajanian G.K. Nitric oxide and carbon monoxide activate locus coeruleus neurons through a cGMP-dependent protein kinase: involvement of a nonselective cationic channel. J. Neurosci. 16:1996;1389-1399.
38. Rasmussen K. The role of the locus coeruleus and N-methyl-D-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal. Neuropsychopharmacology. 13:1995;295-300.
39. Rasmussen K., Beitner-Johnson D.B., Krystal J.H., Aghajanian G.K., Nestler E.J. Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J. Neurosci. 10:1990;2308-2317.
40. Svensson T.H. Peripheral, autonomic regulation of locus coeruleus noradrenergic neurons in brain: putative implications for psychiatry and psychopharmacology. Psychopharmacology. 92:1987;1-7.
41. Taylor J.R., Elsworth J.D., García E.J., Grant S.J., Roth R.H., Redmond D.E. Jr. Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal. Psychopharmacology. 96:1988;121-134.
42. 2-adrenoceptor and μ-opioid receptor densities during morphine dependence and spontaneous withdrawal in rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 336:1987;530-537.
43. Vaupel D.B., Kimes A.S., London E.D. Comparison of 7-nitroindazole with other nitric oxide synthase inhibitors as attenuators of opioid withdrawal. Psychopharmacology. 118:1995;361-368.
44. Vaupel D.B., Kimes A.S., London E.D. Further in vivo studies on attenuating morphine withdrawal: isoform-selective nitric oxide synthase inhibitors differ in efficacy. Eur. J. Pharmacol. 324:1997;11-20.
45. Vincent S.R., Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience. 46:1992;755-784.
46. Williams J.T., Egan T.M., North R.A. Enkephalin opens potassium channels on mammalian central neurons. Nature. 299:1982;74-77.
47. Xu Z.Q., Pieribone V.A., Zhang X., Grillner S., Hökfelt T. A functional role for nitric oxide in locus coeruleus: immunohistochemical and electrophysiological studies. Exp. Brain Res. 98:1994;75-83.